Concepedia

Publication | Open Access

Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial

DOIFull Paper Access

84

Citations

10

References

2017

Year

Babafemi Taiwo, Vincent C. Marconi, Baiba Berzins, Carlee Moser, Amesika N. Nyaku, Carl J. Fichtenbaum, Constance A. Benson, Timothy Wilkin, Susan L. Koletar, Jonathan Colasanti,
Clinical Infectious Diseases

Abstract

NCT02263326.

References

YearCitations

Page 1